NCT00152464View on ClinicalTrials.gov

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

PHASE3CompletedINTERVENTIONAL
Enrollment

514

Participants

Timeline

Start Date

March 20, 2002

Primary Completion Date

March 15, 2006

Study Completion Date

March 15, 2006

Conditions
Dermatitis, Atopic
Interventions
DRUG

Placebo

Pharmaceutical form: Oral drops Route of administration: Oral use

DRUG

Levocetirizine

Pharmaceutical form: Oral drops Concentration: 5 mg/ml Route of administration: Oral use

All Listed Sponsors
lead

UCB Pharma SA

INDUSTRY

NCT00152464 - Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) | Biotech Hunter | Biotech Hunter